search
Back to results

Zona Pellucida Thinning Versus Drilling During Laser-assisted Hatching

Primary Purpose

Infertility

Status
Recruiting
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Zona pellucida thinning
Zona pellucida drilling
Sponsored by
National Research Centre, Egypt
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Infertility

Eligibility Criteria

25 Years - 40 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients who have a previous ICSI failure, unexplained infertility or male infertility

Exclusion Criteria:

  • Patients with hydrosalpinx, pyosalpinx, endometriosis, or uterine fibroids

Sites / Locations

  • Private IVF CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Zona pellucida thinning

Zona pellucida drilling

Arm Description

thinning will be performed without reaching the inner membrane of the Zona pellucida thickness.

an opening will be made from the outside to the inside of the Zona pellucida.

Outcomes

Primary Outcome Measures

Implantation rate
Implantation rate = the total number of early gestational sacs/the total number of transferred embryos × 100%.

Secondary Outcome Measures

Clinical pregnancy rate
Clinical pregnancy rate = the number of pregnancy cycles/the total number of transfer cycles × 100%.

Full Information

First Posted
March 27, 2022
Last Updated
October 19, 2022
Sponsor
National Research Centre, Egypt
search

1. Study Identification

Unique Protocol Identification Number
NCT05311553
Brief Title
Zona Pellucida Thinning Versus Drilling During Laser-assisted Hatching
Official Title
Zona Pellucida Thinning Versus Drilling During Laser-assisted Hatching of Human Embryos in Intracytoplasmic Sperm Injection
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 1, 2020 (Actual)
Primary Completion Date
December 30, 2022 (Anticipated)
Study Completion Date
December 30, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
National Research Centre, Egypt

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Two hundred cycles will be enrolled (100 laser-assisted thinning and 100 laser-assisted drillings). They will be compared regarding the implantation and clinical pregnancy rates
Detailed Description
Two hundred cycles will be enrolled (100 laser-assisted thinning and 100 laser-assisted drillings). All study participants will undergo controlled ovarian stimulation by GnRH agonist long protocol starting from mid-luteal phase. The complete pituitary suppression will be confirmed by serumE2 level less than 30 pg/ml and serum LH level less than 2 mIU/ml, then gonadotropin therapy will be started from day 2 to the day of maturation confirmed by the presence of 3 mature follicles or more, one of them 18 mm; at this time 10000 IU of hCG will be administered then ovum pick up done 36 hours after hCG administration under transvaginal ultrasound guidance Cumulus cell masses around the oocytes will be removed using pull-and-cut denudation pipettes in a 5-well culture dish (MTG, Bruckberg, Germany) containing 27 IU/mL of hyaluronidase. All oocytes that will be mature at 4-6 h after oocyte collection will be inseminated according to the quality of the spermatozoa and oocytes and the patient's previous IVF history. Fertilization will be confirmed 17-18 h after insemination by the presence of two distinct pronuclei. Zygotes will be cultured in 30-μL micro-drops with a 1-step medium and overlaid with paraffin oil in an atmosphere of 6% CO2, 5%O2, and 95% humidity at 37 °C. The available embryos will be assessed in all patients according to the criteria of equal and regular blastomeres, a viable blastomere number, and fragmentation ratio. LAH will be conducted using a Laser System with a 1.48-μm diode-laser at 300 m W through thinning or drilling. The embryos will undergo either LAT or LAD in 10- to 20-μL micro-drops consisting of G-MOPS plus medium. The embryos will be fixed in the micro-drops on the inverted microscope. The size of one laser shot will be 5μm in the ZP using the same total number of 3000-μs pulses. In LAT, the goal of the thinning method is to make the outer portion of the outer protective glycoprotein layer thinner. The laser thinning will be performed by making 2-3 holes without reaching the inner membrane at a depth of60-80% of the ZP thickness. In LAD, the laser opening will be made from the outside to the inside of the ZP. The laser beam shot towards the ZP above the perivitelline space between two blastomeres to minimize the risk of harming the embryo, under careful control. The embryos in the micro-drop will be washed several times after LAH and then transferred to a 1-well dish (Falcon 353,653, USA) containing G-2 culture medium. LAH was performed 2 to 3 h before embryo transfer. The embryos will be cultured in an atmosphere of 6% CO2, 5% O2, and 95% humidity at 37 °C.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Zona pellucida thinning
Arm Type
Experimental
Arm Description
thinning will be performed without reaching the inner membrane of the Zona pellucida thickness.
Arm Title
Zona pellucida drilling
Arm Type
Experimental
Arm Description
an opening will be made from the outside to the inside of the Zona pellucida.
Intervention Type
Procedure
Intervention Name(s)
Zona pellucida thinning
Intervention Description
Laser-assisted hatching will be conducted using a Laser System with a 1.48-μm diode laser at 300 m W through thinning. The laser thinning will be performed by making 2-3 holes without reaching the inner membrane at a depth of60-80% of the Zona pellucida thickness.
Intervention Type
Procedure
Intervention Name(s)
Zona pellucida drilling
Intervention Description
Laser-assisted hatching will be conducted using a Laser System with a 1.48-μm diode laser at 300 m W through drilling. The laser opening will be made from the outside to the inside of the Zona pellucida.
Primary Outcome Measure Information:
Title
Implantation rate
Description
Implantation rate = the total number of early gestational sacs/the total number of transferred embryos × 100%.
Time Frame
at 6 weeks of pregnancy
Secondary Outcome Measure Information:
Title
Clinical pregnancy rate
Description
Clinical pregnancy rate = the number of pregnancy cycles/the total number of transfer cycles × 100%.
Time Frame
at 6 weeks of pregnancy

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients who have a previous ICSI failure, unexplained infertility or male infertility Exclusion Criteria: Patients with hydrosalpinx, pyosalpinx, endometriosis, or uterine fibroids
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mazen Abdel-Rasheed
Phone
+201111242366
Email
doctor_mazen@hotmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ahmed Ayoub
Organizational Affiliation
National Research Centre, Egypt
Official's Role
Principal Investigator
Facility Information:
Facility Name
Private IVF Center
City
Cairo
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ahmed Ayoub

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Zona Pellucida Thinning Versus Drilling During Laser-assisted Hatching

We'll reach out to this number within 24 hrs